Medtech Talk
A weekly conversation with the innovators who will change how health care is delivered.
- Update frequency
- every 25 days
- Average duration
- 38 minutes
- Episodes
- 200
- Years Active
- 2015 - 2025
Everything Medtech Companies Need to Know About Making Friends (& Closing Deals) in China
Chen Yu, MD, managing director of Vivo Capital, has built a career finding the right deals at the right time in the US and China. Hear what US companies can do to take advantage of potential Pan Paci…
00:30:56 |
Fri 26 Aug 2016
Where Are Series A Dollars Coming From? What Areas Are Ripe for M&A? You May Be Surprised
Data guru Jon Norris, managing director at Silicon Valley Bank, reviews his first-half numbers for ophthalmology and life sciences. Norris’ first-half numbers for Medtech start-ups show some surprisi…
00:17:48 |
Fri 19 Aug 2016
ReVision CEO John Kilcoyne Says the Company is Ready to Build a New Medtech Market in Ophthalmology
ReVision Optics built it – a corneal inlay capable of correcting presbyopia. The FDA approved it sooner than expected. Now the company needs to build it into a successful private-pay business.
00:27:34 |
Thu 11 Aug 2016
What Will Carl Zeiss Meditec’s New Ophthalmology Unit Look Like? We Ask Jim Mazzo.
Meet the newest Master of the Industry. Jim Mazzo, who has led divisions, spin-outs, and start-ups, now leads what looks to be a new leader in ophthalmology. Hear how Mazzo views this new opportunity…
00:25:25 |
Thu 04 Aug 2016
From an "Ah, Ha!" Moment to Restoring Sight – Innovator Mark Humayun, MD, on What Drives Innovation
Over two decades ago, Mark Humayun – who will co-chair our upcoming OIS@ASRS meeting in San Francisco – helped launch a “moonshot” that would eventually restore vision for retinitis pigmentosa patien…
00:24:24 |
Wed 27 Jul 2016
Cartiva’s FDA Win for Approval of First Synthetic Cartilage Signals Change for Orthopedics
Cartiva secured an historic win when the FDA approved its synthetic cartilage. CEO Tim Patrick explains what it took to get the approval and how the company will sell going forward.
00:33:48 |
Thu 21 Jul 2016
Perfecting the Fast-Follower Strategy – How Blue Belt Built and Sold a Successful Robotics Business
Eric Timko, the former CEO of Blue Belt, shares how the company used MAKO’s wake to build a market for its surgical robot and sell the business to Smith & Nephew. Timko explains the company’s fast-fo…
00:29:14 |
Thu 14 Jul 2016
How Do You Build a Start-Up into a $600 Million Exit? We Ask Matt Likens, Former CEO of Ulthera
The board at Ulthera, an aesthetics device company, faced an attractive dilemma. Take the company public? Or accept a lucrative buyout? Hear from the CEO how the company’s culture and approach led to…
00:40:05 |
Thu 07 Jul 2016
Gilde Healthcare’s Geoff Pardo on Why European LPs & VCs See Opportunity in the US Medtech Market
Gilde Healthcare Partner Geoff Pardo shares how the firm will invest its new $250 million in health care companies, including Medtech.
00:35:43 |
Thu 30 Jun 2016
Allen Partners’ Julie Allen on How New Leaders Can Find Success in Today’s Evolving Medtech Sector
Julie Allen, principal of Allen Partners, shares insights on how Medtech executives must work to find the right fit and how companies can build their best team.
00:40:35 |
Thu 23 Jun 2016
Sounds from the Stage: Hear "What it Takes to Win in Medtech" from Four Successful CEOs
The experienced CEOs on this panel have authored some of the greatest stories in Medtech. In this discussion, they delve into their approaches to managing start-ups to multi-million – or billion – do…
00:36:29 |
Thu 16 Jun 2016
Medtronic’s Martha Discusses Fear, Transformation & Acquisitions
Medtronic executive VP Geoff Martha talks with OISTV about how the Medtech giant views robotics, payers, and where health care transformation is the most difficult. The podcast also includes a clip f…
00:24:29 |
Thu 09 Jun 2016
Where are we in the Robotics Revolution?
For years, Intuitive Surgical appeared to be the only company capable of cracking the code for medical robotics. But with companies like Medtronic, Stryker, Johnson & Johnson, Google, and others crea…
00:33:30 |
Fri 03 Jun 2016
How Vascular Solutions Beat the DOJ & What Medtech Executives Need to Know to Do the Same
After five years and $25 million, Vascular Solutions CEO Howard Root watched a jury confirm what he knew all along. His company had done nothing wrong. In this interview, Root and Mark Duval, who is …
00:34:45 |
Thu 26 May 2016
MDMA’s Leahey Updates on Device Tax, Reimbursement & What the White House Says About Medtech
Mark Leahey, CEO and President of MDMA, delivers his “State of the Industry” address on reimbursement, the medical device tax, UnitedHealthcare/Medtronic and a little bit of Presidential Politics.
00:17:52 |
Thu 19 May 2016
Facteau Looks Forward to Day in Court & Eyes Funding for Earlens
A recent jury decision cleared Vascular Solutions of charges of improper off-label marketing. Former Acclarent CEO Bill Facteau discusses his indictment in a similar case, the coming court case, and …
00:15:24 |
Sun 15 May 2016
How Will Abbott & Auris Deals Impact Early Stage Start-ups?
Abbott’s move to acquire St. Jude demonstrates how Medtronic’s moves toward “Total Solutions” may change the game in Medtech. We’re going to tackle that topic at the June 1 Medtech Conference. Our c…
00:21:14 |
Tue 03 May 2016
Newly Minted VC Stacy Enxing Seng Talks Medtech, Medtronic & Why She Joined Lightstone
Though initially surprised by Medtronic’s move to buy Covidien, Stacy Enxing Seng says she immediately saw the wisdom of the deal and recognized the opportunity for a fresh start. In an interview, En…
00:25:16 |
Thu 28 Apr 2016
Thom Gunderson Offers Insights on Innovation, IPOs, and Google from a Long-time Medtech Market Watcher
Thomas Gunderson watched the Medtech market for over 20 years at Piper Jaffray. Now recently retired, Gunderson explains how innovation in Medtech is changing, what big strategics think, and where Go…
00:32:38 |
Thu 21 Apr 2016
Windham’s Yee on Why She Thinks Medtech’s Renaissance is Drawing Future New Leaders
Cynthia Yee, a principal at Windham Venture Partners, opened her firm’s office in San Francisco. Yee shares her opinions on many medtech questions including 510(k) versus PMA, the power of payers, an…
00:17:30 |
Thu 14 Apr 2016
Disclaimer: The podcast and artwork embedded on this page are the property of Healthegy. This content is not affiliated with or endorsed by eachpod.com.